Picture of Tate & Lyle logo

TATE Tate & Lyle News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

REG - Tate & Lyle PLC - Result of Annual General Meeting 2025

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250724:nRSX4763Sa&default-theme=true

RNS Number : 4763S  Tate & Lyle PLC  24 July 2025

Tate & Lyle PLC

 

Result of Annual General Meeting 2025

 

Tate & Lyle PLC (the 'Company') announces that at its Annual General
Meeting ('AGM') held earlier today, all resolutions contained in the Notice of
Annual General Meeting 2025 issued on 3 June 2025 were duly passed.

 

The results of the poll held at the AGM are as follows:

 

 

 Resolution                                                                         Total For((1))             Total Against             Votes withheld((2))
         No. of votes                                                               % of vote    No. of votes  % of vote   No. of votes
 1.      Report and Accounts                                                        346,214,388  99.99         41,754      0.01          207,544
 2.      Directors' Remuneration Policy                                             335,249,944  97.75         7,732,103   2.25          3,481,639
 3.      Directors' Remuneration Report                                             260,025,653  75.81         82,978,316  24.19         3,459,717
 4.      Approve final dividend                                                     344,289,578  99.99         33,635      0.01          2,140,473
 5.      Re-elect David Hearn                                                       323,314,691  93.91         20,983,235  6.09          2,165,760
 6.      Re-elect Nick Hampton                                                      340,517,246  98.90         3,773,478   1.10          2,172,962
 7.      Elect Sarah Kuijlaars                                                      342,249,202  99.41         2,039,926   0.59          2,174,558
 8.      Re-elect Jeffrey Carr                                                      334,912,242  97.27         9,389,327   2.73          2,162,117
 9.      Re-elect John Cheung                                                       335,322,858  97.39         8,979,711   2.61          2,161,117
 10.     Re-elect Dr Isabelle Esser                                                 291,493,971  85.98         47,526,592  14.02         7,443,123
 11.     Elect Glenn M.Fish                                                         340,809,705  98.99         3,484,366   1.01          2,169,615
 12.     Elect Steve Foots                                                          341,461,689  99.18         2,835,839   0.82          2,166,158
 13.     Re-elect Kimberly Nelson                                                   338,244,546  98.24         6,056,085   1.76          2,163,055
 14.     Re-elect Warren Tucker                                                     320,752,964  93.16         23,545,370  6.84          2,165,352
 15.     Elect Cláudia Vaz de Lestapis                                              343,521,989  99.78         770,708     0.22          2,170,989
 16.     Re-appoint Ernst & Young LLP                                               345,648,205  99.95         187,803     0.05          627,678
 17.     Approve auditors' remuneration                                             346,246,882  99.95         185,847     0.05          30,957
 18.     Authority to make political donations                                      344,895,608  99.56         1,507,509   0.44          60,569
 19.     Authority to allot ordinary shares                                         311,532,415  89.93         34,899,632  10.07         31,639
 20.     Authority to disapply pre-emption rights                                   324,621,321  93.72         21,746,841  6.28          95,524
 21.     Additional authority to disapply pre-emption rights for an acquisition or  303,753,602  88.28         40,309,809  11.72         2,400,275
         specified capital investment
 22.     Authority to purchase own shares                                           346,256,145  99.96         138,645     0.04          68,896
 23.     Authority in respect of shorter notices for general meetings               335,675,209  96.90         10,751,308  3.10          36,737

 

 

While all Resolutions were passed, most with significant majorities in favour,
the Board notes that 24.19% of the Shareholders voted against Resolution 3,
which concerns the advisory vote on the Company's 2025 Directors' Remuneration
Report. The Board has actively engaged with shareholders on remuneration in
2025 which has helped build a more detailed understanding of shareholder views
and allowed the Board to provide context on the decisions made. We note that
Resolution 2, which relates to the binding vote on the new Directors'
Remuneration Policy, was approved by 97.75% of the Shareholders at the AGM. We
will continue to engage and an update will be published within six months of
today's Annual General Meeting, in accordance with the UK Corporate Governance
Code.

 

( (1)) Includes discretionary votes.

 

((2)) A 'vote withheld' is not a vote in law and is not counted in the
calculation of the proportion of votes 'For' or 'Against' a resolution.

 

On 22 July 2025 there were 476,739,802 ordinary shares in issue, with
31,294,579 ordinary shares held in treasury, so the total voting rights were
445,445,223.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions passed as
special business at the AGM will shortly be available to view via the National
Storage Mechanism at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

Matthew Joy

Company Secretary

24 July 2025

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGPKQBNBBKDFOB

Recent news on Tate & Lyle

See all news